Dr. Lal PathLabs Ltd (BOM:539524)
₹ 3032.8 -65.45 (-2.11%) Market Cap: 252.57 Bil Enterprise Value: 242.94 Bil PE Ratio: 63.01 PB Ratio: 12.63 GF Score: 99/100

Q3 2021 Dr. Lal PathLabs Ltd Earnings Call Transcript

Jan 29, 2021 / 11:15AM GMT
Release Date Price: ₹2247.35 (-0.10%)
Operator

Ladies and gentlemen, good day, and welcome to Dr. Lal PathLabs Q3 FY '21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nishid Solanki from CDR India. Thank you, and over to you, sir.

Nishid Solanki
CDR India - IR Manager

Thank you. Good afternoon, everyone, and welcome to Dr. Lal PathLabs Q3 and 9 months FY '21 Earnings Conference Call. Today, we are joined by senior members of the management team, including Honorable Brigadier Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath, CEO; Mr. Ved Prakash Goel, CFO; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Let me share our disclaimer here. Some of the statements made on today's call could be forward-looking in nature, and the actual results could vary from these forward-looking statements. A detailed statement in this regard is available in the results presentation, which has been circulated to you and is also available on the stock

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot